UK Addiction Treatment

What UK Addiction Treatment does

UK Addiction Treatment (UKAT) is the largest privately-operated residential addiction treatment network in the United Kingdom by centre count and CQC-regulated bed capacity. Founded in 2012 and headquartered in Borehamwood under the legal entity UKAT Group Limited, the company operates 10 residential rehab centres across England spanning Essex, Surrey, Sussex, Oxfordshire, Bedfordshire, West Yorkshire, Cheshire, South Yorkshire, Dorset, and the West Midlands/Warwickshire, providing 240 regulated detox and rehab beds. Its service surface covers medical detox, primary residential rehab, secondary transitional care, sober living, aftercare, and family programmes for substance addictions (alcohol, illicit and prescription drugs, legal highs, antidepressants), behavioural addictions (gambling, gaming, porn, sex/love, internet, social media, food, shopping), and co-occurring mental health conditions including eating disorders.

The company's offering is structured as a four-stage treatment pathway (Primary → Secondary → Sober Living → Aftercare/Alumni) with standard programme lengths of 7, 14, 28, and 90 days. All clients receive one year of free aftercare, and completers of the 90-day programme receive a complimentary 28-day readmission if they relapse within 30 days of discharge. Treatment is led by staff with lived experience of recovery, supported by medically qualified clinicians such as Dr Mateen Durrani (Medical Reviewer). UKAT's technology footprint is intentionally non-proprietary: a content-managed website, SEO-optimised educational content, social channels across Facebook/X/Instagram/LinkedIn/YouTube, a Recovery Podcast, validated screening tools (CAGE, DAST-10), and a UKAT GPT chatbot deployed on OpenAI's ChatGPT platform. No API, no proprietary clinical platform, and no AI/ML research output are disclosed.

UKAT's revenue is generated primarily from private self-pay clients paying £1,500–£3,000 per week, with supplementary funding from private health insurance (Bupa, AXA, Cigna, WPA) and NHS/statutory commissioning. GTM is direct-to-consumer via a 24/7 helpline, online admissions, and walk-ins, augmented by inbound insurance and NHS referral channels. The company has grown through acquisitions of established regional providers (most recently Providence Projects in Bournemouth, July 2025), while closing its London clinic in 2026.

Name

UK Addiction Treatment

Legal name

UKAT Group Limited

Website

https://ukat.co.uk

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

51–100 employees

Short description

UK Addiction Treatment (UKAT) is a UK-based private provider operating 10 CQC-registered residential rehab centres with 240 beds across England, delivering medical detox, residential rehab, and aftercare for substance and behavioural addictions to self-pay, insured, and NHS-funded clients.

Ownership category

akta.pro rank

Product category

Residential Addiction Treatment

NAICS

Residential Mental Health and Substance Abuse Facilities (623220), Residential Mental Health and Substance Abuse Facilities (62322), Outpatient Mental Health and Substance Abuse Centers (621420)

SIC

Services-Nursing & Personal Care Facilities (8050), Services-Social Services (8300)

akta.pro primary industry

Residential Mental Health Treatment Centers (HLAFACAC)

akta.pro secondary industry

Peer Support, Recovery Coaching & Sober Living Services (HLAFACAN)

Keywords

• Addiction treatment
• Residential rehabilitation
• Medical detox
• Dual diagnosis
• Aftercare services

Headquarters

HQ city

Borehamwood

HQ country

United Kingdom

HQ region

Europe

Offices11 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Others

Revenue model

1. Private Self-Pay Treatment: The majority of UKAT's revenue comes from private clients who pay out-of-pocket for residential addiction treatment programmes. Pricing ranges from approximately £1,500 to £3,000 per week, with programme durations typically spanning 7, 14, 28, or 90 days. Clients select from tiered packages ranging from budget-friendly clinics to luxury en-suite facilities with gyms.
2. Private Health Insurance: UKAT partners with major private health insurers — Bupa, AXA, Cigna, and WPA — to fund addiction treatment for insured clients. Insurance-covered admissions represent a secondary revenue stream, with insurers reimbursing treatment costs according to client policy terms.
3. Statutory / NHS Funding: UKAT accepts statutory funding and NHS/commissioner referrals for residential addiction treatment, through dedicated admission pathways for clients working with statutory funders or commissioners.
4. Aftercare and Alumni Services: One year of free aftercare is included with all treatment programmes. Extended outpatient counselling and sober living arrangements may generate additional revenue for clients requiring prolonged support.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Core offering

UKAT operates a network of 10 CQC-registered residential addiction treatment centres across England, delivering medical detox, primary rehabilitation, secondary care, sober living, and one year of free aftercare. Programmes (7, 14, 28, 90-day, or bespoke) combine evidence-based therapies (CBT, DBT, 12-step) and holistic care, funded primarily through private self-pay, private health insurance (Bupa, AXA, Cigna, WPA), and NHS/statutory commissioning.

Product overview

UKAT is a UK-based provider of addiction treatment services operating a network of 10 residential rehab centres across England. The company offers a complete continuum of care through its treatment pathway model: Primary Care (residential detox and rehabilitation), Secondary Care (transitional supported care), Sober Living (independent living with peer support), and Aftercare/Alumni programmes. UKAT's centres include Sanctuary Lodge (Essex), Primrose Lodge (Surrey), Recovery Lighthouse (West Sussex), Banbury Lodge (Oxfordshire), Liberty House (Bedfordshire), Oasis Recovery Bradford, Oasis Recovery Runcorn, Linwood House (Yorkshire), Providence Projects (Bournemouth), and Bayberry Wellness (West Midlands/Warwickshire). Treatment programmes range from 7 to 28 days or bespoke durations, with therapies including CBT, DBT, 12-step therapy, and holistic approaches. The company also provides assessment tools (CAGE, DAST-10), family support programmes, and digital resources including a custom UKAT GPT assistant.

Differentiator

Problem solved

Functional benefit

Products and services

• Sanctuary Lodge

Quantifiable outcome

• 93% of graduated clients are still in recovery one year after treatment (closed survey of UKAT's graduated clients)
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered core and minor.

• BupacoreChannel Partner/ Reseller/ DistributorUKAT is a recognised provider for Bupa-funded addiction treatment. Clients with Bupa health insurance can access UKAT's residential rehab programmes with costs covered under their policy.
• AXAcoreChannel Partner/ Reseller/ DistributorUKAT accepts AXA health insurance for addiction treatment admissions, allowing AXA policyholders to access UKAT's network of CQC-registered centres.
• CignacoreChannel Partner/ Reseller/ DistributorUKAT is partnered with Cigna for addiction treatment coverage, enabling Cigna-insured clients to receive funded treatment at UKAT centres.
• WPA (Western Provident Association)coreChannel Partner/ Reseller/ DistributorUKAT accepts WPA health insurance policies for addiction treatment, providing WPA members with access to UKAT's residential treatment programmes.
• Department of Health (Historical)minorStrategic or Co-development PartnerOasis Recovery Bradford was originally commissioned by the Department of Health as the only detox unit of its kind in West Yorkshire when it was built in 2009, indicating historical government commissioning of UKAT services.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• American Addiction Centers: American Addiction Centers is a US publicly listed operator of residential and outpatient addiction treatment facilities with multi-state coverage. It is comparable to UKAT as a scaled, multi-site residential addiction provider with tiered facility offerings, insurance contracts, and outcome-based marketing — though operating in a different geography and regulatory environment.
• Priory Group: Priory Group is the largest private mental health and addiction treatment provider in the UK, operating a national network of hospitals and clinics. It is comparable to UKAT as the most direct large-scale competitor in UK private residential addiction treatment, with a broader mental-health portfolio but overlapping self-pay, insurance, and NHS commissioning channels.
• Hazelden Betty Ford Foundation: Hazelden Betty Ford is the largest US non-profit addiction treatment provider, operating residential and outpatient programmes across the United States. It is comparable to UKAT in residential addiction treatment philosophy (12-step, CBT/DBT, medically supervised detox) and recovery outcome positioning, although it operates in a different geography and under a non-profit model.

Emerging players

• Quit Genius (Pelago): Pelago (formerly Quit Genius) is a digital substance-use and behavioural-health platform delivering virtual therapy and clinician-led programmes to employers, health plans, and consumers. It competes with UKAT for self-pay and corporate-wellness-funded addiction treatment demand with a lower-cost, tech-enabled delivery model rather than residential beds.

Direct peers

• Castle Craig Hospital: Castle Craig is a UK residential addiction rehab operating a multi-bed facility in Scotland with medically supervised detox and 12-step programming. It competes directly with UKAT in private residential rehab admissions, particularly for UK-wide and international self-pay clients seeking CQC-equivalent regulated care.
• Delamere Health: Delamere is a UK private residential addiction and mental health retreat offering bespoke programmes and 24/7 clinical care. It directly competes with UKAT's premium tier (e.g. Bayberry, Primrose Lodge) for high-net-worth self-pay clients seeking luxury rehab environments.
• Smarmore Castle Private Clinic: Smarmore Castle is an Ireland-based residential addiction rehab with medically supervised detox and evidence-based therapy programmes. It competes directly with UKAT for UK and international self-pay clients seeking CQC/equivalent-regulated residential rehab in a comparable geography.
• Broadway Lodge: Broadway Lodge is a UK residential addiction treatment centre in Somerset providing detox, primary care, and secondary care programmes. It is a direct competitor to UKAT's mid-tier residential centres for self-pay and NHS-funded admissions in the South West of England.
• Phoenix Futures: Phoenix Futures is a UK charity providing residential and community-based addiction recovery services, including rehab and structured day programmes. It is comparable to UKAT for NHS-funded and lower-acuity residential placements, though its funding model and scale differ.

Regional players

• The Kusnacht Practice: The Kusnacht Practice is a Swiss luxury residential addiction and mental health provider serving an international, predominantly UK-sourced private-pay clientele. It competes with UKAT's premium tier for high-end UK self-pay clients willing to travel abroad for treatment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ukatcouk
• YouTubeyoutube.com/c/UKATrehabs
• Facebookfacebook.com/ukatrehabs
• LinkedInlinkedin.com/company/uk-addiction-treatment-limited
• Instagraminstagram.com/ukat_rehabs

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UK Addiction Treatment